Boston’s Deal News: Tracelytics, Tesaro, & A New Innovation Center

3/28/12Follow @xconomy

This week’s New England dealmakers included a venture capital firm, an e-commerce site, a biotech startup, software makers, and even the city of Boston.

—Boston-based OpenView Venture Partners announced it had closed $200 million for its third investment fund, after three months of courting its limited partners.

—Shoptiques, a New York-based fashion tech company whose founder comes from Harvard Business School, opened up about the “large seed round” it raised from Andreessen Horowitz, Greylock Partners, Benchmark Capital, SV Angels, and Y Combinator. The startup also officially opened its e-commerce site for shopping boutiques across the country.

—Waltham, MA-based cancer drug developer Tesaro filed paperwork with the SEC indicating its plans to raise $86 million in an initial public offering and trade on the NASDAQ under the symbol TSRO.

—Tracelytics, a Providence, RI-based maker of application performance management software, nabbed $5.2 million in a Series A financing round led by Bain Capital Ventures. The money also comes from Tracelytics seed investors Google Ventures, Battery Ventures, and Flybridge Capital Partners, and will be used in part to open up a Boston office later this spring.

—Waltham-based CloudLock raised $8.7 million in Series B financing to put toward expanding the functionality for its technology that protects enterprise data shared in the cloud. The money comes from Cedar Fund and Ascent Venture Partners.

—Boston’s Mayor Thomas Menino unveiled the city’s plans for a $5.5 million “innovation center” in the Seaport District, the Boston Globe reports. The planned 9,000-square-foot building is to be run by Kendall Square’s Cambridge Innovation Center and will have space for meetings and events, but not office space for individual companies.

By posting a comment, you agree to our terms and conditions.